Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
The study covered 30 apparently healthy individuals and 38 patients with systemic scleroderma. The patients gave their consent to participate in the study in accordance with the World Medical Association Declaration of Helsinki in the current (2013) version (ACR/EULAR). The donors and patients had t...
Main Authors: | O. I. Emelyanova, I. P. Gontar, O. A. Rusanova, I. A. Zborovskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SPb RAACI
2021-01-01
|
Series: | Medicinskaâ Immunologiâ |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2098 |
Similar Items
-
DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01) -
Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01) -
Modern methods of a localized scleroderma diagnostics
by: Moiseyev А.А., et al.
Published: (2016-09-01) -
Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01) -
Perinuclear antineutrophil cytoplasmic antibody positive glomerulonephritis in a case of limited cutaneous scleroderma
by: H Vora, et al.
Published: (2018-01-01)